Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan: Structural Requirements Differ from Those for Responses to Lipopolysaccharide

ABSTRACT The purpose of this study was to identify the functional significance of the binding of soluble CD14 (sCD14) to bacterial peptidoglycan (PGN) and to compare the structural requirements of sCD14 for the binding to PGN and lipopolysaccharide (LPS) and for sCD14-mediated enhancement of PGN- and LPS-induced cell responses. sCD14 did not facilitate the responses of membrane CD14 (mCD14)-negative pre-B 70Z/3 cells to PGN, although it facilitated the responses of these cells to LPS and although mCD14 facilitated the responses of 70Z/3 cells to PGN. sCD14 enhanced mCD14-mediated cell activation by both PGN and LPS, but only the responses to LPS, and not to PGN, were enhanced by LPS-binding protein. Four 4- or 5-amino-acid-long sequences within the 65-amino-acid N-terminal region of sCD14 were needed for binding to both PGN and LPS and for enhancement of cell activation by both PGN and LPS. However, deletions of individual sequences had different effects on the ability of sCD14 to bind to PGN and to LPS and on the ability to enhance the responses to PGN and to LPS. Thus, there are different structural requirements of sCD14 for binding to PGN and to LPS and for the enhancement of PGN- and LPS-induced cell activation.

[1]  R. Dziarski,et al.  Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and Endotoxin* , 2000, The Journal of Biological Chemistry.

[2]  R. Darveau,et al.  CD14 Employs Hydrophilic Regions to “Capture” Lipopolysaccharides , 2000, The Journal of Immunology.

[3]  J. Mathison,et al.  Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide* , 2000, The Journal of Biological Chemistry.

[4]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[5]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[6]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[7]  R. Dziarski,et al.  Endothelial and epithelial cells do not respond to complexes of peptidoglycan with soluble CD14 but are activated indirectly by peptidoglycan-induced tumor necrosis factor-alpha and interleukin-1 from monocytes. , 1998, The Journal of infectious diseases.

[8]  R. Tapping,et al.  Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.

[9]  R. Tapping,et al.  Cellular Binding of Soluble CD14 Requires Lipopolysaccharide (LPS) and LPS-binding Protein* , 1997, The Journal of Biological Chemistry.

[10]  H. Flad,et al.  Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes , 1997, Infection and immunity.

[11]  R. Dziarski,et al.  Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. , 1996, The Journal of infectious diseases.

[12]  T. Kirkland,et al.  CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.

[13]  M. C. Hu,et al.  Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. , 1996, Journal of immunology.

[14]  S. Wright,et al.  Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein , 1996, The Journal of Biological Chemistry.

[15]  J. Gegner,et al.  Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.

[16]  M. Kelley,et al.  Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (*) , 1995, The Journal of Biological Chemistry.

[17]  T. Kirkland,et al.  A Region of Human CD14 Required for Lipopolysaccharide Binding (*) , 1995, The Journal of Biological Chemistry.

[18]  H. Flad,et al.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.

[19]  R. Dziarski,et al.  Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. , 1994, The Journal of biological chemistry.

[20]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[21]  K. Kato,et al.  Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. , 1993, Journal of immunology.

[22]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[23]  A. Ulmer,et al.  Interactions of Bacterial Lipopolysaccharide and Peptidoglycan with Mammalian CD14 , 2002 .

[24]  A. Ulmer,et al.  Interactions of CD14 with components of gram-positive bacteria. , 2000, Chemical immunology.

[25]  R. Menzel,et al.  Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. , 1997, European journal of biochemistry.

[26]  R. Dziarski,et al.  Isolation of peptidoglycan and soluble peptidoglycan fragments. , 1994, Methods in enzymology.